After Tariff Flush, a Fresh Look at AbbVie Pharma (ABBV)

In my 2025 Outlook, I picked AbbVie Pharmaceuticals (NYSE: ABBV) as one to watch this year.Here is what I wrote: AbbVie (ABBV) AbbVie primarily works in immunology, oncology, neuroscience, eye care, and virology. It is also the parent company of Allergan, the maker of Botox. Botox is one of the most well-known and widely used aesthetic treatments globally, primarily known for its cosmetic use in reducing wrinkles and fine lines. Hence, it fits in the “Vanity” trade. The monthly chart shows the correctio ...